Blue Water Vaccines, Inc. Files Registration Statement for Initial Public Offering of Common Stock

On October 8, 2021 Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing vaccines, reported that it has filed a registration statement (Registration No.: 333-260137) on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock (Press release, Onconetix, OCT 8, 2021, View Source [SID1234641101]). The shares of common stock to be sold in the offering are expected to be offered by the Company. The number of shares to be offered and the price range for the proposed offering have not yet been determined.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Maxim Group LLC will serve as sole book-running manager for the proposed offering. The Company plans to use the proceeds from this offering to fund its research and development activities, for working capital and other general corporate purposes. The proposed offering will be made only by means of a prospectus, which forms a part of the registration statement. Copies of the registration statement and the preliminary prospectus included therein relating to the proposed offering, when available, may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov.

A registration statement on Form S-1 (Registration No.: 333-260137)relating to the proposed sale of these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.